✦ LIBER ✦

Early use of glycoprotein IIb/IIIa inhibitors in the ED treatment of non-ST-segment elevation acute coronary syndromes: a local quality improvement initiative

✍ Scribed by Francis M Fesmire; Eric D Peterson; Matthew T Roe; James F Wojcik

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of non–ST-segment-elevation ac

✍ Matthew T Roe; David J Moliterno 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Early Glycoprotein IIb/IIIa Inhibitor Us

✍ James W. Hoekstra; Matthew T. Roe; Eric D. Peterson; Venu Menon; Jyotsna Mulgund 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Trials of glycoprotein IIb-IIIa inhibito

✍ W. W. Parmley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Use of platelet glycoprotein IIb/IIIa in

✍ Timm Bauer; Helge Möllmann; Franz Weidinger; Uwe Zeymer; Ricardo Seabra-Gomes; F 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 302 KB

Low-molecular-weight heparin compared wi

✍ Kanwar P. Singh; Matthew T. Roe; Eric D. Peterson; Anita Y. Chen; Kenneth W. Mah 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 292 KB

Early vs. late administration of glycopr

✍ G. Montalescot; M. Borentain; L. Payot; J.P. Collet; D. Thomas 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 38 KB